Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors - Wikidata - wikimedia - TriplyDB

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

http://www.wikidata.org/entity/Q42136944

about

Site-Specific Genome Engineering in Human Pluripotent Stem Cells Advances in cell culture: anchorage dependence.A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes A Versatile Bioreactor for Dynamic Suspension Cell Culture. Application to the Culture of Cancer Cell Spheroids Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.Nutrient regulation by continuous feeding removes limitations on cell yield in the large-scale expansion of Mammalian cell spheroids.Cleavage of E-cadherin and β-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013 Optimization of agitation speed in spinner flask for microcarrier structural integrity and expansion of induced pluripotent stem cells.Hydrodynamic modulation of pluripotent stem cells Expansion of mesenchymal stem cells under atmospheric carbon dioxide.Bioreactor design for clinical-grade expansion of stem cells.Bioreactors as engineering support to treat cardiac muscle and vascular disease.Bioreactor Development for Lung Tissue Engineering.Impact of fluidic agitation on human pluripotent stem cells in stirred suspension culture.Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids.Scaling up a chemically-defined aggregate-based suspension culture system for neural commitment of human pluripotent stem cells.Periodic harvesting of embryonic stem cells from a hollow-fiber membrane based four-compartment bioreactor.Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System.Pluripotent stem cells for disease modeling and drug screening: new perspectives for treatment of cystic fibrosis?Current state and perspectives in modeling and control of human pluripotent stem cell expansion processes in stirred-tank bioreactors.Stem Cell Spheroids and Ex Vivo Niche Modeling: Rationalization and Scaling-Up.Adaptation to robust monolayer expansion produces human pluripotent stem cells with improved viability.Review: bioreactor design towards generation of relevant engineered tissues: focus on clinical translation.Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Perfused Three-Dimensional Multicompartment Bioreactor.Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation: considerations on process development.Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools.Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture.Cell fiber-based three-dimensional culture system for highly efficient expansion of human induced pluripotent stem cells.Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.Live fluorescent RNA-based detection of pluripotency gene expression in embryonic and induced pluripotent stem cells of different species.Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks.Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application.Serum replacement with albumin-associated lipids prevents excess aggregation and enhances growth of induced pluripotent stem cells in suspension culture.Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes.Differentiation of cardiomyocytes and generation of human engineered heart tissue.

P2860

Q26747006-26D05ABC-690E-41D8-8EA8-889FFBE55126 Q27015670-C03CBC80-901C-4FB3-A2DE-D2B12F23E591 Q27301270-9A7CB777-4AFC-4647-8B1A-227046780043 Q27349039-C05279E7-9613-4680-9176-88DA5D75EA90 Q28817482-6F2E98DA-DD9F-4852-89D6-130A33598E01 Q30395748-FE7C1C84-7AB1-4946-AFE1-63B40101DEC8 Q30447478-7160B991-B905-415C-AC50-D2D0EB90E380 Q30575493-27D3258F-BC68-4DF4-BCE7-9EBB96F3FD55 Q33663350-086721D1-455C-4DDD-988A-5472181E928B Q33730144-A2B1669E-FE33-47A7-A256-33735B1C9E5F Q35620068-47B64BF1-7B4E-4A05-8E8A-C909D7B18376 Q36422075-468031B9-2876-4D32-AAF6-297CE14DB5E4 Q36633029-9A5D9ECE-D507-4DDE-8034-50CB3BD01844 Q37515677-7F31D98C-016F-4AC7-9EEF-689BD00FF7C6 Q38102652-AC50EF7F-540A-4859-95C4-6F6DE276330A Q38130597-75918A8C-E592-4252-8A4B-A100DE1049C4 Q38366596-80788DF8-2894-4C22-A400-4F613476234D Q38686685-A4CB4794-EFAF-4AB6-A4FE-39B186F54362 Q38739153-2563FBA8-E6BF-486C-AFC6-FEE2D9157680 Q38809980-CC7E8185-B374-44F3-88DE-4C46EDFA25B9 Q38826307-BD84EB5A-7A40-44FF-AEED-4CBA3EF3B90D Q38864756-15FFBDEB-5348-4E98-83DD-342FBC99879D Q38932077-D7338B45-EB0C-4238-B632-BB127EF323B9 Q39055581-400CF1E9-E2EB-416C-A30D-6A16400263EB Q39177046-E6579BAE-103C-42F4-8224-AFF53DE8F24B Q39181538-1825421D-4E55-4750-8247-ED38DCA80753 Q39218394-0C964947-2566-4303-AC19-A810524FA52D Q39638005-333C98DC-4E01-4C4A-A0DE-04B7F24455CA Q40965254-DC53299B-15FC-4DC7-97C2-306B156DEE71 Q41073477-1A8F5552-15EF-47AA-82EA-DA756828BBFD Q41231682-183E872F-E1B3-4DDD-9024-B380731A3451 Q41779162-A8B698BA-6ED0-4E0D-858F-2B17FFC14B0A Q41869556-486455FB-560D-4797-9E11-709D65D18C80 Q42606543-883726C2-CA97-4415-B533-8E53A4F3A206 Q46823027-BFC9276A-B793-4C77-9ECE-15D3654AB7CE Q47197637-5D819E45-6116-4CBB-9A43-D9281F946357 Q47270959-10EDBB40-BD21-4407-AD69-1595F0D03D2F Q47794085-EC168E1F-5A7B-45AC-AF7A-B972DCEE64D4 Q47909800-6203E4CA-76D4-491C-A117-581DCCAE1825 Q48061816-DAC3E193-2CD9-4FAE-88A3-7C8AFFD14514

P2860

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

http://www.wikidata.org/entity/Q42136944

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

@en

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

@nl

type

label

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

@en

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

@nl

prefLabel

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

@en

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

@nl

P1433

Q42136944-328972CA-C26C-4BCB-8C6C-5EAFDAC5B5F3

P1476

Q42136944-FAA31401-3A77-49DC-BEFB-F5EB49F74A77

P2093

Q42136944-202B3902-457E-42E1-BA69-03D1A1B86B5A

Q42136944-2A99A19D-C1B6-4D8E-A3E3-23E20D3C7D7F

Q42136944-64B0EE1C-6E4A-4132-8898-4D358A6A19C3

Q42136944-8DA559B0-F575-44AC-AD63-7746273267A9

Q42136944-FE9D8035-17CE-4B2E-AD1A-4E9B2C52DD73

P2860

Q42136944-049D485C-AC59-4324-93A9-0A1A53083441

Q42136944-0CEFE147-01A5-4A79-A73D-97D6EC15FCE1

Q42136944-19364D0E-813B-4A56-9CD5-577753004030

Q42136944-1BE45025-CD22-4424-873D-4CFB995A533E

Q42136944-1E5A9BC0-0D9D-45DE-AD58-4718AF850F0F

Q42136944-1FDCD24D-5780-4681-B167-91C94FFF5FF5

Q42136944-200683D9-3E95-49EE-802D-C7AFB580CB44

Q42136944-220FBC37-2D5D-478C-AE1D-63C1974D413A

Q42136944-2F7F86BB-8778-4E25-AAAE-C864DA9A1BE1

Q42136944-3AC26F9E-80A6-4332-96FF-E9AB0974E6E3

P304

Q42136944-F7AEEF63-AAFE-4BF3-AA14-429594235DC5

P31

Q42136944-3BD7FB9E-E5CB-44E1-824E-C3A606707653

P356

Q42136944-58CFE07E-74AD-461B-8D50-BCF36EB09057

P433

Q42136944-7D850A9F-1D7F-4855-BE22-7DAE58CC60B3

P478

Q42136944-FABE2E66-8A8A-43B6-B270-3F64334E6883

P50

Q42136944-103ED8E0-D244-452A-B229-25C78994A542

Q42136944-E92E803A-EC15-44FB-9886-31C849AE0CEA

P577

Q42136944-79D81C6D-42A0-4938-9B9E-A62E811F5CC8

P5875

Q42136944-BEF56C35-3568-4B49-978A-82766B301E54

P698

Q42136944-68DA6EF5-5186-4978-8003-88A8B340A27E

P932

Q42136944-C76565A6-E4A4-44A2-96DB-083B8CF611CB

P356

TEN.TEC.2011.0717

P1433

Tissue Engineering. Part C. Methods

P1476

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

@en

P2093

Andreas Lange

http://www.w3.org/2001/XMLSchema#string

Cornelia Kasper

http://www.w3.org/2001/XMLSchema#string

Robert Zweigerdt

http://www.w3.org/2001/XMLSchema#string

Ruth Olmer

http://www.w3.org/2001/XMLSchema#string

Sebastian Selzer

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

A ROCK inhibitor permits survival of dissociated human embryonic stem cells

Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.

Reactor engineering in large scale animal cell culture

Scalable stirred-suspension bioreactor culture of human pluripotent stem cells.

The multiparametric effects of hydrodynamic environments on stem cell culture.

Feeder-independent culture of human embryonic stem cells.

The different shades of mammalian pluripotent stem cells.

Generation of insulin-producing beta cells from stem cells--perspectives for cell therapy in type 1 diabetes.

Stem cells for heart cell therapies

P304

772-784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/TEN.TEC.2011.0717

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224808424

http://www.w3.org/2001/XMLSchema#string

P698

22519745

http://www.w3.org/2001/XMLSchema#string

P932

3460618

http://www.w3.org/2001/XMLSchema#string